Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview Article

Targeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders

David H. Farb and Marcia H. Ratner
Leslie A. Morrow, ASSOCIATE EDITOR
Pharmacological Reviews October 2014, 66 (4) 1002-1032; DOI: https://doi.org/10.1124/pr.114.009126
David H. Farb
Laboratory of Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcia H. Ratner
Laboratory of Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie A. Morrow
Laboratory of Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts
Roles: ASSOCIATE EDITOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 66 no. 4 1002-1032
DOI 
https://doi.org/10.1124/pr.114.009126
PubMed 
25237115

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online September 18, 2014.

Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. David H. Farb and
  2. Marcia H. Ratner
  1. Laboratory of Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts
  1. Leslie A. Morrow, ASSOCIATE EDITOR
  1. Address correspondence to:
    Dr. David H. Farb, Laboratory of Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118. E-mail: dfarb{at}bu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2018 to August 2022

AbstractFullPdf
Jan 2018106832
Feb 201865542
Mar 2018512043
Apr 2018044133
May 201809451
Jun 201826122
Jul 2018014730
Aug 2018246626
Sep 2018227829
Oct 2018233729
Nov 2018345218
Dec 2018051115
Jan 2019345817
Feb 2019241457
Mar 2019524248
Apr 2019317876
May 2019815167
Jun 201906242
Jul 201936447
Aug 201925647
Oct 201969612
Nov 2019961023
Dec 2019131910
Jan 202044217
Feb 202022618
Mar 202024031
May 202088135
Jun 202034526
Jul 20201448
Aug 202035817
Sep 202033279
Oct 20207554
Nov 20206534
Dec 20204512
Jan 20215985
Feb 20213949
Mar 20216682
Apr 2021130116
May 202116937
Jun 20217181
Jul 20214052
Aug 20213114
Sep 20216442
Oct 20214231
Nov 20215622
Dec 20216332
Jan 20224642
Feb 20224962
Mar 20225042
Apr 20229777
May 20227575
Jun 20226534
Jul 20225463
Aug 20221011

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 66 (4)
Pharmacological Reviews
Vol. 66, Issue 4
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Targeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview Article

Targeted Modulation of Neural Circuits Implicated in Anxiolysis

David H. Farb and Marcia H. Ratner
Pharmacological Reviews October 1, 2014, 66 (4) 1002-1032; DOI: https://doi.org/10.1124/pr.114.009126

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleReview Article

Targeted Modulation of Neural Circuits Implicated in Anxiolysis

David H. Farb and Marcia H. Ratner
Pharmacological Reviews October 1, 2014, 66 (4) 1002-1032; DOI: https://doi.org/10.1124/pr.114.009126
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. Types of Anxiety Disorders
    • III. Brain-Imaging Studies: Assessment of Brain Activation in Patients with Anxiety Disorders
    • IV. Neural Systems and the Neurochemical Basis of Anxiety
    • V. Neuropsychopharmacology of Anxiety Disorders
    • VI. Conclusions
    • Acknowledgements
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Molecular Mechanisms of CO-Mediated Signaling
  • Pharmacology of Matrix Metalloproteinases
  • Quantitative Proteomics in Translational Pharmacokinetics
Show more Review Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics